Tag: Imraldi

Another Humira biosimilar hits EU shores

by Selina McKee | Oct 17, 2018 | News | 0

Samsung Bioepis has announced the European launch of Humira biosimilar Imraldi, as NHS chiefs tell Trusts to ensure they are ready to realise the potential savings from using cheaper versions of the world’s biggest selling drug.

EMA advisors back eight medicines for approval

by Selina McKee | Jun 26, 2017 | News | 0

Eight medicines have been backed for approval by the European Medicines Agency’s Committee for Medicinal Products for Human Use, including new therapies to treat hepatitis C, multiple sclerosis and cancer.